Verification, clinical evaluation, and FDA clearance of the world's first culture-free phenotypic ID/AST diagnostic platform
Active Definitive Contract Awarded Last action
- Contract number
- 75A50124C00042
- Awardee
-
Pattern Bioscience, Inc. UEI KGNTWWVCEM33
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $22,500,000
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 55% obligated
-
- $22,500,000.00 Current, with exercised options
- $40,937,536.73 Potential, with all options
- Completion date 48% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Sharing
- Place of performance
- Austin, TX 78759, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $22,500,000 |
About this award
Pattern Bioscience, Inc., an Austin, Texas-based biotechnology firm specializing in advanced diagnostic platforms, was awarded a $40.9M definitive cost-sharing contract by the Office of the Assistant Secretary for Preparedness and Response on September 26, 2024. The contract, with an ultimate completion date of January 31, 2029, supports verification, clinical evaluation, and FDA clearance of a culture-free phenotypic identification and antimicrobial susceptibility testing diagnostic platform. This award originated from a Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement seeking proposals for advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic threats. While the Trustees of Boston University serves as the prime contractor, Pattern Bioscience is functioning as a major subcontractor on this initiative. No set-aside designation was applied to this award.
The diagnostic platform being developed addresses a critical clinical need by enabling rapid pathogen identification and determination of antimicrobial susceptibility without requiring culture-based methods, thereby supporting faster, more targeted antibiotic treatment decisions. The technology is designed to work directly from non-sterile specimens while reducing system complexity and testing costs. By significantly shortening the empiric treatment time window, the platform aims to improve patient outcomes and help preserve the efficacy of critical antibiotics. This contract represents a continuation of Pattern Bioscience's collaborative development efforts with ASPR and BARDA, building upon earlier grant sub-awards received through Boston University beginning in 2021.
Quick answers
Who was awarded contract 75A50124C00042?
75A50124C00042 was awarded to Pattern Bioscience, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 26, 2024.
How much is contract 75A50124C00042 worth?
The government has obligated $22,500,000 on 75A50124C00042. Its potential value, with all options, is $40,937,537.
Was contract 75A50124C00042 competed?
The extent of competition for 75A50124C00042 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award